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Background: Mycoplasmosis is a common infection in human and veterinary medicine, and is associated with
chronic inflammation and high morbidity. Mycoplasma species are often intrinsically resistant to many conventional
antimicrobial therapies, and the resistance patterns of pathogenic mycoplasmas to commonly used medicinal
(antimicrobial) plant extracts are currently unknown.
Methods: Aqueous extracts, ethanol extracts, or oils of the targeted plant species and colloidal silver were prepared
or purchased. Activity against the wall-less bacterial pathogen Mycoplasma mycoides subsp. capri was determined
and compared to activities measured against Escherichia coli and Bacillus subtilis. Antimicrobial susceptibility testing
was performed by broth microdilution assays. The lethal or inhibitory nature of each extract was determined by
subculture into neat growth medium.
Results: Growth of M. mycoides capri, E. coli, and B. subtilis was inhibited by elderberry extract, oregano oil, ethanol
extract of oregano leaves, and ethanol extract of goldenseal root. No inhibition was seen with aqueous extract of
astragalus or calendula oil. Growth of M. mycoides capri and B. subtilis was inhibited by ethanol extract of astragalus,
whereas growth of E. coli was not. Similarly, M. mycoides capri and E. coli were inhibited by aqueous extract of
thyme, but B. subtilis was unaffected. Only B. subtilis was inhibited by colloidal silver. Measured MICs ranged from
0.0003 mg/mL to 3.8 mg/mL. Bacteriostatic and bactericidal effects differed by species and extract.
Conclusions: The atypical pathogen M. mycoides capri was sensitive to extracts from many medicinal plants
commonly used as antimicrobials in states of preparation and concentrations currently available for purchase in the
United States and Europe. Variation in bacteriostatic and bactericidal activities between species and extracts
indicates that multiple effecter compounds are present in these plant species.Background
Atypical bacteria lack or produce aberrant forms of cellu-
lar components that characterize most bacterial species.
Members of the genus Mycoplasma lack cell walls, do not
synthesize nucleotides or amino acids, express an unusual
form of RNA polymerase, and certain species produce
atypical ribosomes [1]. These biological features make
mycoplasmas intrinsically resistant to many antibiotics,
and successful treatment options are restricted to tetracy-
clines, macrolides, and fluoroquinolones. Mycoplasma* Correspondence: mmay@towson.edu
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reproduction in any medium, provided the orinfections are a grave concern in veterinary medicine,
where they are associated with detrimental and economic-
ally burdensome infections in production animals inclu-
ding cattle, goats, swine, chickens, and turkeys [2]. Human
mycoplasmosis is associated with numerous clinical mani-
festations, most notably community acquired pneumonia
and nongonococcal urethritis [3,4].
The in vitro inhibitory effects of goldenseal (Hydrastis
canadensis), huang qi (Astragalus membranaceus), oregano
(Origanum vulgare), thyme (Thymus vulgaris), elderberry
(Sambucus nigra), and calendula (Calendula officinalis)
have been observed and reported for true gram-positive
and gram-negative bacteria (Table 1) [5-10]. Their effect on
wall-less atypical bacteria such as mycoplasmas is virtually
unexplored. A small number of ethnopharmacologicalLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Plant sources used in this studya
Plant Common name Active compound Chemical family Extract spectrum Reference
Hydrastis canadensis Goldenseal Berberine Alkaloid G+, G- [8]
Astragalus membranaceus Astragalus Polysaccharides (?) Polysaccharide Unk [9]b, [13]
Origanum vulgare Oregano Carvacrol, Thymol Phenol G+, G- [6,14]
Thymus vulgaris Thyme Carvacrol Phenol G+, G- [10]
Sambucus nigra Elderberry Tannins, lupeol Flavonoid, Triterpene G+, G- [7,15,16]
Calendula officinalis Calendula Unk N/A Unk [5]
aAbbreviations: G + (Gram positive); G- (Gram negative), Unk (unknown); N/A (not applicable).
bReference is a review article.
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plants used in Jordan [11] and Nigeria [12] but the impact
of botanicals widely used in the United States and Europe
on mycoplasmas remains unknown. The lack of classical
antimicrobial targets make mycoplasmas intrinsically resist-
ant to many antibiotics [1], and it is unknown if they are
similarly resistant to crude and purified extracts from plants
commonly used to treat infections in botanical medicine.
We examined commercial extracts of the H. canadensis,
A. membranaceus, O. vulgare, T. vulgaris, S. nigra, and
C. officinalis for efficacy against the small ruminant patho-
gen Mycoplasma mycoides subsp. capri. Whole plant
extracts and colloidal silver (commercial or freshly prepared)
were used at retail concentrations and preparations to better
simulate the conditions under which these compounds
would be utilized to treat infection in vivo. The aim of this
study is to determine the efficacy of several commercial
and fresh extracts of plants commonly used in botanical
medicine (Hydrastis canadensis, Astragalus membranaceus,
Origanum vulgare, Thymus vulgaris, Sambucus nigra, and









Elderberry-365 365 Everyday Value
Oregano-LE Gaia Herbs
Oregano oil North American Herb and Spice
Thyme Nature’s Answer
Calendula Eclectic Institute
Colloidal silver Source Naturals
aAbbreviations: N/A (not applicable/extracts produced for this study); Aq (aqueous e
bStarting concentrations are those reported for commercial products, and were not
cRole of additional components: C12H22O11 (sucrose)-sweetener; C3H8O3 (glycerol)-te
extract-ascorbic acid supplementation, anti-inflammatory properties, additional anti
dConcentration reported by the manufacturer refers to total alkaloids rather than pspecies that lack many common antimicrobial targets,
represented here by M. mycoides capri. Escherichia coli and
Bacillus subtilis were used as a standard for comparison
with eubacterial species in our experimental setting.
Methods
Bacterial strains and culture conditions
Mycoplasma mycoides subspecies capri strain GM12 was
cultured in American Type Culture Collection (ATCC)
medium 988 (SP-4) containing 20% v/v fetal bovine
serum and 1% w/v D-glucose. Escherichia coli strain
DH5α and Bacillus subtilis strain ATCC 6051 (MarburgT
strain) were cultured in modified trypticase soy (mT-soy)
medium supplemented with 0.002% w/v phenol red,
1% w/v D-glucose, and 1% w/v D-mannitol to ensure co-
lorimetric visualization of growth. All cultures were incu-
bated at 37°C.
Plant extracts
Commercial preparations (aqueous, ethanol, or oil) of H.
canadensis, A. membranaceus, O. vulgare,T. vulgaris, S. nigra,ation (mg/mL)b Solvent Additional componentsc
100 Water None
100 95% ethanol None
500 50% ethanol None
100 Water None
100 95% ethanol None
10d 65% ethanol None
380 Water C12H22O11, Acerola extract
100 Water C3H8O3, C6H7KO2
333 65% ethanol None
1667 Olive oil None
1000 15% ethanol C3H8O3
945 Olive oil None
0.03 Water None
xtract); ETOH (ethanol extract); Com (commercial extract); LE (leaf extract).
normalized to maximize relevance to common use practices.
xture, sweetener; C6H7KO2 (potassium sorbate)-antifungal preservative; Acerola
microbial properties28.
lant material.
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trations in mg/mL reflect a w/v measurement of crude plant
material to solvent. Aqueous and ethanol extracts of H. cana-
densis and A. membranaceus were prepared as previously
described [17] (referred to as “fresh” or “freshly prepared”).
Briefly, 10 g dried, ground plant material was suspended in
100 mL of molecular-grade water or 95% ethanol. Cellular
materials were disrupted by sonication, and suspensions were
rapidly shaken on an orbital shaker for 48 hours. Material in
suspension was removed by repeated centrifugation at 4,000
RPM followed by vacuum filtration through a 0.45 μM pore
nitrocellulose membrane. Fresh and commercial extracts were
stored at 4°C.
Antimicrobial susceptibility testing
Stock cultures of M. mycoides capri, E.coli, and B. subtilis
were diluted to 0.5 McFarland standard in sterile SP-4 or
mT-soy medium. Minimum inhibitory concentrations
(MIC) were determined by broth microdilution as pre-
viously described [18] using SP-4 or mT-soy as the dilu-
ents for serial 10-fold dilutions of extracts. 10% solutions
of molecular grade water, 95% ethanol (i.e., 9.5% final
concentration), and olive oil were inoculated with each
species to control for the effect of plant extract solvents.
Starting concentrations of each extract ranged from 1667
to 0.03 mg/mL and are reported in Table 2. Broth micro-
dilution assays were incubated for 18 hours at 37°C. Bac-
terial growth was noted by acidification of the medium
observed colorimetrically by shifting of the pH indicator
phenol red. The bacteriostatic versus bactericidal nature
of the extracts was determined by subculture from wells
containing inhibitory dilutions into neat SP-4 or mT-soy
medium (broth and agar) at 37°C. Bactericidal activity of
an extract was noted after incubation for 7 days and an
absence of colonies on agar plates. Minimum bacterio-
static concentrations (MBCs) were recorded. All suscep-
tibility tests were performed three distinct times.
Results and discussion
The efficacy of commercial and fresh extracts of plants
commonly used in botanical medicine to treat infection
(Hydrastis canadensis, Astragalus membranaceus, Ore-
ganum vulgare, Thymus vulgaris, Sambucus nigra, and
Calendula officinalis) and colloidal silver against an
atypical pathogenic bacterial species that lacks many
common antimicrobial targets was examined. Represen-
tative species were selected for analysis based on prece-
dent in antimicrobial assessments of botanical extracts
(gram negative species E. coli and gram positive species
B. subtilis) or in vitro growth characteristics (atypical
species M. mycoides capri) [19,20]. Mycoplasmas are no-
toriously fastidious, but M. mycoides capri grows well in
axenic culture and thus is ideal for in vitro analysis.
Microdilution was selected over disk-diffusion becauseseveral recent studies have reported greater experimental
sensitivity with broth microdilution [21,22]. Intraspecies
diversity in resistance to many conventional antibiotics
has been noted for M. mycoides capri and may also exist
for the included antimicrobial extracts [23,24], therefore
the use of a single strain represents a limitation of this
work. Future studies including numerous strains are
needed prior to recommending a standard concentration
for treatment with extracts; however, this study repre-
sents an essential first step in establishing a baseline ex-
pectation for susceptibility using strain GM12.
We found a wide range of resistance and sensitivities
with the compounds tested, two of which conflicted with
previous findings (Table 3) indicating higher sensitivity
of gram positive bacteria to goldenseal alkaloids (analo-
gous to our commercial goldenseal) than of E. coli [25],
and sensitivity of E. coli to colloidal silver by qualitative
methods [26]. Growth of M. mycoides capri, E. coli, and
B. subtilis was inhibited by all tested elderberry extracts,
oregano oil, ethanol extract of oregano leaves, and fresh
ethanol extract of goldenseal root. No inhibition was
seen with aqueous extract of astragalus or calendula oil.
Growth of M. mycoides capri and B. subtilis was inhi-
bited by fresh ethanol extract of astragalus, whereas
growth of E. coli was not. Similarly, M. mycoides capri
and E. coli were inhibited by a commercial ethanol ex-
tract of thyme, but B. subtilis was unaffected. Only
B. subtilis was inhibited by colloidal silver, and only M.
mycoides capri was inhibited by fresh aqueous extract of
goldenseal root. No inhibition was observed for any spe-
cies with the extract solvents (i.e., molecular grade water,
95% ethanol, or olive oil).
While inhibition of B. subtilis and M. mycoides capri
was observed for the fresh astragalus ethanol extract, the
commercial ethanol extract and the fresh aqueous extract
were ineffective. Our data suggest that the antimicrobial
component of A. membranaceus is not water-soluble,
and that the commercial preparation tested does not
retain the component. While we did not observe any
inhibition with calendula oil, other studies have documen-
ted its positive contribution to wound healing [27-30].
Calendula is associated with lymphocyte activation [15],
angiogenesis [30], and alleviation of irritations [31], so it
is plausible that its role in healing is due primarily to
immune modulation and stimulation of tissue repair
rather than antimicrobial activity.
The MICs of compounds that exhibited growth inhi-
bition are presented in Table 3. Measured MICs ranged
from 0.0003 mg/mL to 3.8 mg/mL. Commercial ethanol
extracts of astragalus differed in their measured MICs
from our laboratory-prepared ethanol extracts for B.
subtilis and M. mycoides. Commercial ethanol extracts
of goldenseal root differed from our laboratory-prepared
ethanol extracts for all three species tested (Table 3).
Table 4 Post-inhibition analysisa
Compound E. coli B. subtilis M. mycoides capri
Astragalus-Aq resistant resistant resistant
Astragalus- ETOH resistant bacteriostatic bactericidal
Astragalus-com resistant resistant resistant
Goldenseal-Aq resistant resistant bacteriostatic
Goldenseal-ETOH bacteriostatic bactericidal bacteriostatic
Goldenseal-com bactericidal resistant resistant
Elderberry (365) bactericidal resistant bactericidal
Elderberry (G) bacteriostatic bacteriostatic bacteriostatic
Oregano leaf bactericidal bactericidal bactericidal
Oregano oil bactericidal bactericidal bacteriostatic
Colloidal Silver resistant bactericidal bactericidal
Thyme bactericidal resistant bactericidal
Calendula resistant resistant resistant
aDefinition of terms: “resistant”-species was resistant to the compound; no
analysis performed; “bacteriostatic”: compound was shown to be
bacteriostatic by growth upon subculture; “bactericidal”: compound was
shown to be bactericidal by lack of growth upon subculture. N = 2 replicates.
Table 3 Minimum inhibitory and bacteriostatic concentrationsa
Extract E. coli B. subtilis M. mycoides capri
MIC (mg/mL) MBCb (mg/mL) MIC (mg/mL) MBCb (mg/mL) MIC (mg/mL) MBCb (mg/mL)
Astragalus-Aq >10 N/A >10 N/A >10 N/A
Astragalus-ETOH >10 N/A 0.001 0.001 1.0 BC
Astragalus-Com >50 N/A >50 N/A >50 N/A
Goldenseal-Aq >10 N/A >10 N/A 0.05 0.5
Goldenseal-ETOH 1.0 1.0 1.0 BC 1.0 1.0
Goldenseal-Comc 0.1 BC >1 N/A >1 N/A
Elderberry-G 0.0038 0.0038 3.8 3.8 0.38 0.38
Elderberry-365 0.1 BC >10 N/A 0.001 BC
Oregano-LE 0.033 BC 0.00033 BC 0.033 BC
Oregano oil 0.167 BC 0.0167 BC 0.092 0.167
Thyme 1.0 BC >100 N/A 0.5 BC
Calendula >95 N/A >95 N/A >95 N/A
Colloidal silver >0.003 N/A 0.0003 0.0003 >0.003 N/A
Water NI N/A NI N/A NI N/A
95 % Ethanol NI N/A NI N/A NI N/A
Olive oil NI N/A NI N/A NI N/A
aN = 3 replicates; MIC/MBC concentrations reflect mean values across trials. Abbreviations: N/A (not applicable); BC (bactericidal); NI (no inhibition by solvents at
the lowest dilution [1:10]). Efficacious compounds with a measureable inhibitory concentration or bactericidal activity are bolded.
bColumns marked N/A or BC indicate that MBCs could not be determined due to lack of inhibition (N/A) or bactericidal activity (BC).
cConcentration reflects total alkaloid content.
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Herbs and 365 Everyday Value) had measurable differ-
ences in MIC for all three species (Table 3). Finally,
whole oregano oil and ethanol extract of oregano leaf
showed measurably different MICs for all three organ-
isms (Table 3). The subculture of inhibited wells into
neat SP-4 or mT-soy medium indicated a range of bac-
teriostatic and bactericidal effects that differed by species
and extract (Table 4). Aqueous extract of goldenseal and
one preparation of elderberry extract (Gaia Herbs) were
uniformly bacteriostatic across inhibited species, and
oregano oil, the second preparation of elderberry extract
(365 Everyday Value), and thyme extract were uniformly
bactericidal across inhibited species. The remaining
extracts were static for certain species and lethal for
others (Table 4).
S. nigra (elderberry) has been traditionally used to treat
influenza, but a small number of additional studies show
that this compound inhibits growth of gram positive and
gram negative bacteria [25,32]. Inhibition was observed for
both formulations of elderberry used in this study, but dir-
ect comparisons are difficult to make due to additional
components in the formulation. The Gaia Herbs formula-
tion contained acerola extract, which has also been reported
to have antimicrobial activity [14]. However, Motohashi
et al. reported the acerola was ineffective against all gram
negative bacteria tested, while gram positive bacteria were
sensitive. We found the MIC of the gram negative E. coli
was 100-fold lower than the MICs of the gram positive B.subtilis and the atypical M. mycoides capri for this formula-
tion of elderberry, indicating that acerola was not a major
component of the observed inhibition. The antifungal and
antibacterial preservative potassium sorbate (C6H7KO2)
was added to the 365 Everyday Value formulation of elder-
berry. The impact of C6H7KO2 was apparent from the
post-inhibition analysis, where the 365 Everyday Value
formulation was found to be bactericidal and the Gaia
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antibacterial effect of C6H7KO2 is bactericidal [33], and
so the presence of this preservative likely contributes to
the analytic discrepancy and the inhibitory effect of the
365 Everyday Value preparation. While inhibition was
observed for E. coli and M. mycoides capri with this pre-
paration, the MIC was 2-fold higher for E. coli. In con-
trast, the MIC was 100-fold lower for M. mycoides capri,
potentially indicating a greater sensitivity of atypical bac-
teria to the preservative C6H7KO2. Susceptibility testing
using C6H7KO2 alone was not performed, but would
confirm this indication. In further contrast, B. subtilis was
resistant to the 365 formulation of elderberry at concen-
trations above the MIC measured for the Gaia Herbs for-
mulation indicating that either 1.) the differential in MIC
for B. subtilis can be attributed to the anti-gram positive
effects of acerola; 2.) the efficacy of elderberry’s antimicro-
bial components is sensitive to shelf life; or 3.) elderberry
and acerola act synergistically against B. subtilis in a way
that elderberry and C6H7KO2 do not. In any case, it is clear
that there are marked differences in in vitro efficacy be-
tween these formulations for all three representative types
of bacteria.
Comparisons between commercial and freshly pre-
pared ethanol extracts of astragalus and goldenseal root
lend support to the notion of shelf life being an under-
appreciated problem, though differences in processing
or preparation have not been accounted for. Fresh as-
tragalus extract inhibited growth of B. subtilis and M.
mycoides capri, while the commercial extract was inef-
fective against all three species. Similarly, the fresh etha-
nol extract of goldenseal root inhibited the growth of all
three species, while B. subtilis and M. mycoides capri
were completely resistant to the commercial extract.
Curiously, E. coli had a 10-fold lower MIC for the com-
mercial extract, but this is likely due to the reported
concentration reflecting total alkaloid content rather
than the dry weight of the whole root as was the case
for the fresh ethanol extract. The alkaloid berberine is
recognized as the major antibacterial component of
goldenseal root [8], indicating that the commercial ex-
tract should intrinsically have a lower measured MIC
than the fresh ethanol extract. Room-temperature sto-
rage of commercial and freshly prepared extracts with
periodic measurements of the MICs for each would ap-
propriately assess the scale of this problem.
Our data collected from oregano preparations and our
post-inhibition analysis support findings from previous
studies [17] indicating that commercial extracts of medi-
cinal plants contain multiple antimicrobial compounds.
Ethanol extract from oregano leaves had lower MICs
than oil emulsion of whole oregano for all three species,
and this difference was remarkably pronounced for B.
subtilis and M. mycoides capri. This difference likelystems from 1.) differential solubility of antibacterial com-
pounds in oil versus ethanol, 2.) components present in
the stem and root acting antagonistically to the effect
exhibited by components in the leaves, or both. Lambert
et al. reported that multiple antibacterial compounds are
present in oregano plants [34], but this work was later
contradicted by Peñalver et al. who associated the activity
exclusively with the phenolic compound carvacrol [35].
However, there is greater evidence for the presence of
multiple compounds in the form of findings showing a
greater antimicrobial effect of oregano oil than of purified
carvacrol [36]. Similarly, our findings of an extract being
bacteriostatic for one species and bactericidal for another
(as was the case for oregano leaf extract and fresh ethanol
extracts of goldenseal root and astragalus) suggests multiple
components within the same extracts exhorting different
biological effects. This likely explains the unexpected find-
ing of a wide range of sensitivity by M. mycoides capri
when intrinsic antimicrobial resistance is predictable [1].
Our data indicate that commercial preparations of me-
dicinal plants are predictably variable in their MIC and
antibacterial spectrum. Because most are commercial
extracts, however, the concentrations used are relevant to
common usage scenarios despite the extracts having po-
tential to be inhibitory at higher concentrations. Perhaps
surprisingly the wall-less, atypical species M. mycoides
capri was not limited in its sensitivity profile as compared
to the eubacterial species E. coli and B. subtilis.
Conclusion
Interest in botanical medicine has led to widespread
availability of antimicrobial plant extracts in the United
States. We found a wide range of resistance and sensiti-
vities with the compounds tested, the majority of which
were consistent with previous findings for eubacteria. In
the case of thyme ethanol extract, our findings comple-
ment a previous report describing the effects of an aque-
ous extract [37]. The in vitro efficacy of these extracts at
their available concentrations on atypical bacteria is
vastly understudied, and our study represents an import-
ant first step in establishing the efficacy of these com-
pounds as botanical treatments for mycoplasmosis.
Further exploration into the toxicity, bioavailability,
pharmacokinetics, and ultimately the in vivo efficacy
against mycoplasmosis of these extracts will provide evi-
dence for their potential use as treatments or for the dis-
infection of agricultural or clinical fomites such as
milking equipment. Based on the measured antimicro-
bial effects of the medicinal plants we studied, common
commercial preparations of astragalus (ethanol extracts),
goldenseal root (aqueous or ethanol extracts), elderberry,
oregano (leaf extracts or essential oil), and thyme have
potential to be primary or ancillary treatments for myco-
plasmosis, and further study in vivo is required.
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